Veterinary Antimicrobial Susceptibility Testing Market Size
Veterinary Antimicrobial Susceptibility Testing Market size is projected to exhibit substantial growth between 2024 and 2032, owing to the rising threats of antimicrobial resistance. The growing demand for animal-derived products, rising need for pet insurance and higher healthcare spending is driving the increasing government initiatives to tackle antimicrobial resistance.
The increasing number of farm animals and the growing demand for healthy, top-quality animal products are making it more important to test for antimicrobial resistance (AMR). In Europe alone, there were over 20 million dairy cows in 2022. Animal disease prevention efforts are also raising awareness about AMR testing. Government support, new technologies, and more research partnerships are also expected to help the industry grow. But challenges remain. Some veterinarians aren't fully aware of AMR testing, regulations can be a hurdle, and growing concerns about AMR could affect how much demand there is for AMR testing in the future.
Veterinary Antimicrobial Susceptibility Testing Market Trends
The increasing adoption of rapid diagnostic techniques, such as molecular methods and automated systems are facilitating quicker and more accurate testing results. The growing emphasis on implementing antimicrobial stewardship programs in veterinary practices is encouraging responsible antimicrobial use. The integration of data analytics and artificial intelligence (AI) into testing platforms is enabling better interpretation of susceptibility data and guiding treatment decisions. The rise of multiplex testing platforms to detect multiple antimicrobial resistances simultaneously is also gaining traction, further offering enhanced efficiency and cost-effectiveness.
Veterinary Antimicrobial Susceptibility Testing Market Analysis
Based on product, the market value from the automated AST instruments segment is estimated to increase at commendable pace through 2032, owing to the increasing demand for rapid and accurate testing results. Automation streamlines testing processes and reduces turnaround time and labor costs for veterinary practices. The integration of advanced technologies, such as AI enhances data analysis and interpretation, further boosting the efficiency and reliability of automated AST instruments. With innovative computer software, the equipment helps interpret susceptibility patterns for each organism and produces error-free findings.
The animal health industry, particularly in the livestock sector, is projected to dominate the veterinary antimicrobial susceptibility testing market by 2032. This surge is driven by the growing demand for antibiotics and other medications for farm animals worldwide. Data from the National Library of Medicine shows that global antimicrobial sales are expected to jump by 11.5% by 2030, reaching a total of 104,079 tonnes. This sharp increase in microbial sales and their potential overuse is creating a strong need for susceptibility testing. Furthermore, concerns over food safety and the spread of antimicrobial resistance are pushing livestock producers to make regular susceptibility testing a priority. They recognize that it's crucial to ensure the effectiveness of these medications and protect both animals and consumers. In addition, advancements in testing technologies, such as rapid diagnostic methods, are making antimicrobial susceptibility testing faster, more accurate, and more efficient in livestock settings. These innovations are making it easier for producers to manage antibiotic resistance and maintain the health of their animals.
North America veterinary antimicrobial susceptibility testing market size is anticipated to expand at notable rate between 2024 and 2032, due to the increasing prevalence of antimicrobial-resistant infections in animals. The rollout of stringent regulations is promoting responsible antimicrobial use and increasing the awareness among veterinarians and animal owners about the importance of susceptibility testing. The rapid developments in testing technologies and strong presence of established veterinary diagnostics companies will also contribute to the regional industry expansion.
Veterinary Antimicrobial Susceptibility Testing Market Share
Companies operating in the veterinary antimicrobial susceptibility testing industry are adopting various corporate strategies, such as mergers & acquisitions and partnerships to come up with new innovative solutions and expand their consumer base.
Some of the major veterinary antimicrobial susceptibility testing companies are
- BioMérieux SA
- Thermo Fisher Scientific
- Bruker Corporation
- Danaher Corporation
- Becton Dickinson & Company
- Synbiosis
- Liofilchem S.r.l.
- HiMedia Laboratories
- Bio-Rad Laboratories
- Neogen Corporation
- Mast Group Ltd.
- Condalab
- FASTinov
- Hardy Diagnostics
- Bioguard Corporation
- SSI Diagnostica A/S
Veterinary Antimicrobial Susceptibility Testing Industry News
- In August 2022, Becton, Dickinson, and Company partnered with Accelerate Diagnostics to globally distribute Accelerate's rapid antibiotic resistance and susceptibility testing solution with the aim to provide results within hours.
What Information does this report contain?
Historical data coverage 2018 to 2023; Growth Projections 2024 to 2032.
Expert analysis industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts major segments covering applications, top products and geographies.
Competitive landscape reporting market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.
